Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'r pfi 2 hydrochloride'

Search results for: 'r pfi 2 hydrochloride'

Items 11-20 of 80

Page
per page
  1. COTI-2
    C4483 COTI-2
    Summary: activates mutant forms of p53
      ≤1 mg/mL
  2. CBL0137 (hydrochloride)
    C3192 CBL0137 (hydrochloride)
    Summary: curaxin that activates p53 and inhibits NF-κB
      insoluble in EtOH; ≥15.47 mg/mL
  3. AD57 (hydrochloride)
    C3080 AD57 (hydrochloride)
    Summary: polypharmacological cancer therapeutic that inhibits RET.
      ≤5 mg/mL
  4. WEHI-539 hydrochloride
    A8634 WEHI-539 hydrochloride
     1 Citation
    Summary: Bcl-xL inhibitor,high affinity and selective
      ≥28.55 mg/mL
  5. RETRA hydrochloride
    A4485 RETRA hydrochloride
    Summary: Antitumor agent
      <30.58 mg/mL
  6. Sabutoclax
    A4199 Sabutoclax
     2 Citation
    Target: Bcl-2|Mcl-1|Bfl-1
    Summary: pan-Bcl-2 inhibitor
      insoluble in H2O; ≥205.6 mg/mL
  7. PD-1/PD-L1 inhibitor 2
    B6023 PD-1/PD-L1 inhibitor 2
    Target: PD-1/PD-L1 interaction
    Summary: PD-1/PD-L1 interaction inhibitor
      ≥42 mg/mL
  8. Muristerone A
    A4466 Muristerone A
    Summary: TRAIL- and hFasL-induced apoptosis inhibitor
      Soluble in DMSO
  9. Apogossypolone (ApoG2)
    A4200 Apogossypolone (ApoG2)
     2 Citation
    Target: Bcl-2|Bcl-xl|Mcl-1
    Summary: Bcl-2 inhibitor,nonpeptidic small molecule
      ≥24.55 mg/mL
  10. ABT-263 (Navitoclax)
    A3007 ABT-263 (Navitoclax)
     15 Citation
    Target: Bcl-2|Bcl-w
    Summary: Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w
      ≥48.73 mg/mL

Items 11-20 of 80

Page
per page